{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:35:11Z","timestamp":1783823711475,"version":"3.55.0"},"reference-count":17,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Human immunoglobulin G (IgG) includes four different subtypes (IgG1, IgG2, IgG3, and IgG4), and it is also now appreciated that there are genetic variations within IgG subtypes (called isoallotypes). Twenty\u2010nine different isoallotypes have been described, with 7, 4, 15, and 3 isoallotypes described for IgG1, IgG2, IgG3, and IgG4, respectively. The reactivity of anti\u2010IgG with different isoallotypes has not been characterized.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN AND METHODS<\/jats:title><jats:p>A novel monoclonal anti\u2010K antibody (PugetSound Monoclonal Antibody 1 [PUMA1]) was isolated and sequenced, and a panel of PUMA1 variants was expressed, consisting of the 29 known IgG isoallotypes. The resulting panel of antibodies was preincubated with K\u2010positive red blood cells (RBCs) and then subjected to testing with currently approved anti\u2010IgG by flow cytometry, solid phase systems, gel cards, and tube testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>A US Food and Drug Administration (FDA)\u2010approved monoclonal anti\u2010IgG (gamma\u2010clone) failed to recognize 2 of 15 IgG3 isoallotypes (IgG3\u201003 and IgG3\u201013) and 3 of 3 IgG4 isoallotypes (IgG4\u201001, IgG4\u201002, and IgG4\u201003). In contrast, an FDA\u2010approved rabbit polyclonal anti\u2010IgG recognized each of the known human IgG isoallotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>These findings demonstrate \u201cblind spots\u201d in isoalloantibody detection by a monoclonal anti\u2010IgG. If a patient has anti\u2010RBC antibodies predominantly of an IgG3 subtype (the IgG3\u201003 and\/or IgG3\u201013 variety), then it is possible that a clinically significant alloantibody would be missed. IgG\u201003 and IgG\u201013 have an estimated frequency of 1% to 3% in Caucasian populations and 20% to 30% in certain African populations. Nonreactivity with IgG4 is a known characteristic of this monoclonal anti\u2010IgG, but IgG4 isoallotypes have not been previously reported.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.13812","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T06:19:50Z","timestamp":1474006790000},"page":"2953-2962","source":"Crossref","is-referenced-by-count":30,"title":["Serological blind spots for variants of human <scp>I<\/scp>g<scp>G<\/scp>3 and <scp>I<\/scp>g<scp>G<\/scp>4 by a commonly used anti\u2010immunoglobulin reagent"],"prefix":"10.1111","volume":"56","author":[{"given":"Heather L.","family":"Howie","sequence":"first","affiliation":[{"name":"BloodworksNW Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Delaney","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"},{"name":"Departments of Laboratory Medicine and Internal Medicine, Division of Hematology University of Washington Seattle Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay See","family":"Er","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam Amsterdam The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara C.","family":"Stegmann","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, University of Amsterdam Amsterdam The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kapp","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna N.","family":"Lebedev","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Wu","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-6871","authenticated-orcid":false,"given":"James P.","family":"AuBuchon","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"},{"name":"Departments of Laboratory Medicine and Internal Medicine, Division of Hematology University of Washington Seattle Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Zimring","sequence":"additional","affiliation":[{"name":"BloodworksNW Research Institute"},{"name":"Departments of Laboratory Medicine and Internal Medicine, Division of Hematology University of Washington Seattle Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.27.5.359"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25185116496.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03641.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajpa.10405"},{"key":"e_1_2_7_7_1","first-page":"328","article-title":"Autoimmune haemolytic anaemia: serological and immunochemical characteristics of the autoantibodies; mechanisms of cell destruction","volume":"7","author":"Engelfriet CP","year":"1974","journal-title":"Ser Haematol"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33693296807.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916939008993374"},{"key":"e_1_2_7_10_1","first-page":"121","article-title":"Experience in the use of a monoclonal polyspecific anti\u2010human globulin reagent for antibody investigations","volume":"67","author":"Moulds MK","year":"1994","journal-title":"Vox Sang"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25185116499.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32692367205.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1988.tb05087.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400706"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1997.7240233.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30891020331.x"},{"key":"e_1_2_7_17_1","volume-title":"Churchill Livingstone;","author":"Petz LD","year":"2004"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb04999.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.13812","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.13812","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.13812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:17:38Z","timestamp":1695539858000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.13812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1111\/trf.13812"],"URL":"https:\/\/doi.org\/10.1111\/trf.13812","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]}}}